Trial Condition(s):
Skin Mycoses
Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
Bayer Identifier:
2008/01850
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses
Inclusion Criteria
- Diagnosis of skin mycosis
Exclusion Criteria
- Allergies to study medication
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Kashkin Clinical Research Mycological Institute St Petersburg, Russia | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization
Trial Type:
Observational
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physicianTimeframe: Baseline to end of study
Secondary Outcome
- Patient satisfactionTimeframe: Baseline to end of study
Additional Information
Copyright © Bayer
Powered by
